Combinatorial immunotherapy of sorafenib and blockade of programmed death-ligand 1 induces effective natural killer cell responses against hepatocellular carcinoma
Crossref DOI link: https://doi.org/10.1007/s13277-014-2722-2
Published Online: 2014-11-05
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Yun
Li, Hongxia
Liang, Qi
Liu, Bin
Mei, Xiaqi
Ma, Yingji
Text and Data Mining valid from 2014-11-05